CHRONIC MYELOID-LEUKEMIA

被引：0
作者：
TANZER, J
机构：
来源：
NOUVELLE REVUE FRANCAISE D HEMATOLOGIE | 1993年 / 35卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：155 / 160
页数：6
相关论文
共 76 条
[31]  
HAGEMEIJER A, 1987, CLIN HAEMATOL, V1, P963
[32]   ACUTE-LEUKEMIA IN BCR/ABL TRANSGENIC MICE [J].
HEISTERKAMP, N ;
JENSTER, G ;
TENHOEVE, J ;
ZOVICH, D ;
PATTENGALE, PK ;
GROFFEN, J .
NATURE, 1990, 344 (6263) :251-253
[33]  
JOHNSON E, 1992, J BIOL CHEM, V267, P14412
[34]   DIFFERENCES IN ONCOGENIC POTENCY BUT NOT TARGET-CELL SPECIFICITY DISTINGUISH THE 2 FORMS OF THE BCR/ABL ONCOGENE [J].
KELLIHER, M ;
KNOTT, A ;
MCLAUGHLIN, J ;
WITTE, ON ;
ROSENBERG, N .
MOLECULAR AND CELLULAR BIOLOGY, 1991, 11 (09) :4710-4716
[35]   CELL-CYCLE REGULATED BINDING OF C-ABL TYROSINE KINASE TO DNA [J].
KIPREOS, ET ;
WANG, JYJ .
SCIENCE, 1992, 256 (5055) :382-385
[36]  
LEEMHUIS T, 1993, BLOOD, V81, P801
[37]   SEQUENCE-SPECIFIC DNA-BINDING PROTEINS WITHIN THE MBCR ON THE PH1 CHROMOSOME [J].
LEIBOWITZ, D ;
YOUNG, K ;
COX, G .
GENES CHROMOSOMES & CANCER, 1991, 3 (04) :308-312
[38]  
LITZ CE, 1990, CANCER RES, V50, P4984
[39]   TYROSINE KINASE-ACTIVITY AND TRANSFORMATION POTENCY OF BCR-ABL ONCOGENE PRODUCTS [J].
LUGO, TG ;
PENDERGAST, AM ;
MULLER, AJ ;
WITTE, ON .
SCIENCE, 1990, 247 (4946) :1079-1082
[40]  
MANDANAS RA, 1992, LEUKEMIA, V6, P796
12345678